These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 20618823)

  • 1. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
    Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE
    Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports.
    Evans RW
    MedGenMed; 2007 Sep; 9(3):48. PubMed ID: 18092054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
    Orlova Y; Rizzoli P; Loder E
    JAMA Neurol; 2018 May; 75(5):566-572. PubMed ID: 29482205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome.
    Sclar DA; Robison LM; Castillo LV; Schmidt JM; Bowen KA; Oganov AM; Skaer TL; Kogut SJ
    Headache; 2012 Feb; 52(2):198-203. PubMed ID: 22289074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptans, SSRIs/SNRIs and serotonin syndrome.
    Rothrock JF
    Headache; 2010 Jun; 50(6):1101-2. PubMed ID: 20618824
    [No Abstract]   [Full Text] [Related]  

  • 6. Triptans and serotonin syndrome.
    Fine A; Bastings E
    Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?
    Wenzel RG; Tepper S; Korab WE; Freitag F
    Ann Pharmacother; 2008 Nov; 42(11):1692-6. PubMed ID: 18957623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report.
    Meng Y; Yuen J
    J Pharm Pract; 2023 Jun; 36(3):705-710. PubMed ID: 34962845
    [No Abstract]   [Full Text] [Related]  

  • 9. The serotonin syndrome, triptans, and the potential for drug-drug interactions.
    Shapiro RE; Tepper SJ
    Headache; 2007 Feb; 47(2):266-9. PubMed ID: 17300366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?
    Mansuri Z; Adnan M; Shah B; Trivedi C; Vadukapuram R; Patel S; Yadav G; Srinivas S; Ansari M; Makani R; Baweja R; Reddy A
    J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):199-200. PubMed ID: 38227629
    [No Abstract]   [Full Text] [Related]  

  • 11. From the editorial office.
    Rothrock JF
    Headache; 2012; 52(7):1069. PubMed ID: 22755549
    [No Abstract]   [Full Text] [Related]  

  • 12. Is an FDA alert harming patients?
    Schuman E
    JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393
    [No Abstract]   [Full Text] [Related]  

  • 13. Triptans and serotonin syndrome.
    Evans RW
    Cephalalgia; 2008 May; 28(5):573-4; author reply 574-5. PubMed ID: 18355351
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
    Bonetto N; Santelli L; Battistin L; Cagnin A
    Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285
    [No Abstract]   [Full Text] [Related]  

  • 16. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.
    Gillman PK
    Headache; 2010 Feb; 50(2):264-72. PubMed ID: 19925619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say?
    Kogut SJ
    J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions with triptans : which are clinically significant?
    Rolan PE
    CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interaction between a selective serotonin reuptake inhibitor and a triptan leading to serotonin toxicity: a case report and review of the literature.
    Jin G; Stokes P
    J Med Case Rep; 2021 Jul; 15(1):371. PubMed ID: 34304734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy.
    Karkow DC; Kauer JF; Ernst EJ
    J Clin Psychopharmacol; 2017 Oct; 37(5):518-523. PubMed ID: 28796019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.